Fisher had high praise for Merck's CEO and says that, overall, the pharma industry's pipeline is improving. Tune in to Tuesday's interview on Bloomberg, taped the day that Januvia, Merck's Type 2 Diabetes treatment, was approved by FDA.
BLOOM (BLOOM), National
Tue 17 Oct 2006 01:50 PM EDT
Portfolio manager John Fisher weighs in on Big Pharma, with high praise for Merck, whose new Type 2 Diabetes therapy was approved by FDA yesterday